BEGHETTO, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 6.587
EU - Europa 4.555
AS - Asia 3.575
SA - Sud America 424
Continente sconosciuto - Info sul continente non disponibili 123
AF - Africa 67
OC - Oceania 4
Totale 15.335
Nazione #
US - Stati Uniti d'America 6.439
IT - Italia 1.830
GB - Regno Unito 1.058
CN - Cina 1.036
SG - Singapore 1.007
SE - Svezia 442
HK - Hong Kong 371
VN - Vietnam 334
BR - Brasile 329
DE - Germania 298
TR - Turchia 228
FI - Finlandia 177
UA - Ucraina 176
BD - Bangladesh 174
FR - Francia 147
RU - Federazione Russa 114
KR - Corea 107
IN - India 105
CA - Canada 75
NL - Olanda 64
BG - Bulgaria 61
MX - Messico 39
AR - Argentina 35
ID - Indonesia 33
PL - Polonia 25
IQ - Iraq 24
LT - Lituania 21
ES - Italia 19
IE - Irlanda 19
IR - Iran 19
PK - Pakistan 18
BE - Belgio 17
CO - Colombia 16
SA - Arabia Saudita 15
ZA - Sudafrica 15
IL - Israele 14
JP - Giappone 13
EC - Ecuador 12
SI - Slovenia 12
AT - Austria 11
CH - Svizzera 11
EU - Europa 11
CL - Cile 9
MA - Marocco 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
PH - Filippine 8
TH - Thailandia 8
CR - Costa Rica 7
EG - Egitto 7
MY - Malesia 7
NG - Nigeria 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
GR - Grecia 6
JM - Giamaica 6
JO - Giordania 6
PE - Perù 6
RO - Romania 6
VE - Venezuela 6
BY - Bielorussia 5
DK - Danimarca 5
KE - Kenya 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
AU - Australia 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KZ - Kazakistan 4
NP - Nepal 4
PA - Panama 4
RS - Serbia 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
GE - Georgia 3
GT - Guatemala 3
SN - Senegal 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CU - Cuba 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MG - Madagascar 2
NI - Nicaragua 2
PT - Portogallo 2
QA - Qatar 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
CI - Costa d'Avorio 1
GA - Gabon 1
HR - Croazia 1
Totale 15.213
Città #
Southend 781
Santa Clara 773
Singapore 677
Ashburn 580
Woodbridge 461
Fairfield 389
Chandler 385
Hong Kong 364
Jacksonville 323
Hefei 285
Ann Arbor 251
Houston 241
Nyköping 235
Beijing 234
San Jose 232
Dearborn 223
Wilmington 182
Rome 170
Milan 169
London 151
Cambridge 143
Seattle 138
Dallas 132
Izmir 123
Los Angeles 114
Helsinki 110
Seoul 105
Ho Chi Minh City 95
The Dalles 84
New York 81
Buffalo 74
Naples 73
Hanoi 72
Princeton 67
Council Bluffs 59
Modena 58
Sofia 58
Chicago 57
Eugene 57
Frankfurt am Main 57
San Diego 55
Lauterbourg 48
Shanghai 44
Munich 38
Bari 36
Moscow 34
Palermo 33
São Paulo 33
Bologna 32
Florence 31
Des Moines 29
Da Nang 26
Orem 26
Chennai 23
Atlanta 21
Turin 21
Brescia 20
Philadelphia 20
Catania 19
Guangzhou 19
Mexico City 18
Dublin 17
Mumbai 17
Toronto 17
Brussels 16
Elk Grove Village 16
Warsaw 16
Columbus 15
Falkenstein 15
Jakarta 15
Montreal 15
Boardman 14
Memphis 14
Nanjing 14
Salt Lake City 14
Augusta 13
Bremen 13
Haiphong 13
Phoenix 13
San Mateo 13
Turku 13
Baghdad 12
Johannesburg 12
Manassas 12
Stockholm 12
Brooklyn 11
Genoa 11
Ottawa 11
Redwood City 11
Denver 10
Ferrara 10
Kent 10
Kunming 10
Mashhad 10
Norwalk 10
Parma 10
Shenzhen 10
Tokyo 10
Amsterdam 9
Changsha 9
Totale 9.982
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.861
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 362
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 360
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients 345
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 310
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 308
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 308
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 305
Detectable HIV viral load is associated with metabolic syndrome 297
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 293
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 287
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection 280
Associatioin of epicardial adipose tissue with incident coronary heart disease and death in HIV infected patients. 278
Prediction of hard cardiovascular events in HIV patients 276
A randomized, controlled trial to evaluate change in cardiometabolic and endothelial function in HIV-infected patients with optimal viral suppression on Darunavir/ritonavir monotherapy vs. triple-therapy. 274
Severity of lipodystrophy is associated with decreased health-related quality of life 272
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 271
Effectiveness and durability of polyacrylamide hydrogel injections for treating HIV-related facial lipoatrophy 268
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 256
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 255
Age-related comorbidities in people living with HIV 252
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 246
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV 241
Randomized Trial to Evaluate Cardiometabolic and Endothelial Function in Patients with Plasma HIV-1 RNA Suppression Switching to Darunavir/Ritonavir with or without Nucleoside Analogues 232
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 231
ISS-NIA ITALIAN COHORT: NEW ANTI-HIV INHIBITORS IN PATIENTS EXPERIENCED TO IP, NRTI, NNRTI. 229
Does lipodistrophy affect quality of life? 225
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 224
Body Image perception in HIV infected women with body fat redistribution. 221
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 219
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 219
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 218
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 216
Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) study 208
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 207
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 206
How do frailty mediate pathway leading to disability 202
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 201
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the italian version of assessment of body change and distress questionnaire 200
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 196
È possibile un counselling HIV su internet? 196
Virologic failure and metabolic syndrome in patients with HIV infection 193
Validity of body image perception in women with HIV. 188
Virologic failure and metabolic syndrome in patients with HIV infection 186
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 185
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial 181
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 180
Prevalence and risk factors of pubic lipomas in HIV-infected patients 178
Relapse of HIV-related buffalo hump after liposuction 174
Prospective, 48 weeks follow up, multidisciplinary interventionalstudy to assess improvement of adherence in people with lipodistrophy. 173
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 166
Qual è il rapporto tra qualità di vita e lipodistrofia 163
HIV counselling looks for new target and methods web versus face to face counselling 163
Ruolo della chirurgia plastica nel trattamento della sindrome da ridistribuzione del tessuto adiposo 158
Lipodystrophy and quality of life: a prospective study 158
Nuovi obiettivi e strumenti di lavoro nel counselling HIV: studio prospettico osservazionale del counselling informatico versus il counselling vis a vis 149
Metabolic and anthropometric alterations in a population of HIV infected patients with a high prevalence of lipodystrophy: associations with HCV coinfection 147
Gender differences in depression evolution in a cohort of patients attendine a metabolic clinic for lipodystrophy management 138
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 135
Lipodistrophy is related to adherence to antiretroviral therapy (ARV) 134
HIV counselling and prevention on the WEB 131
Totale 15.335
Categoria #
all - tutte 51.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.297


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022914 21 136 62 104 23 43 34 76 95 66 142 112
2022/20231.398 140 121 111 109 121 178 38 152 180 45 107 96
2023/20241.039 60 71 81 130 165 79 91 98 34 49 60 121
2024/20252.816 113 77 60 224 589 403 214 130 336 97 259 314
2025/20264.666 309 222 473 544 541 346 508 268 498 420 281 256
2026/2027163 163 0 0 0 0 0 0 0 0 0 0 0
Totale 15.335